This week, people with asthma not at higher risk for poor COVID-19 outcomes; adherence to asthma biologic therapy higher than inhaled corticosteroids; health care affordability, racial disparities persist in individuals with asthma, COPD; and more.

Read Healio's full coverage here:

https://www.healio.com/news/pulmonology/20210317/people-with-asthma-not-at-higher-risk-for-poor-covid19-outcomes-study-finds

https://www.healio.com/news/pulmonology/20210319/adherence-to-asthma-biologic-therapy-higher-than-inhaled-corticosteroids

https://www.healio.com/news/pulmonology/20210315/health-care-affordability-racial-disparities-persist-in-individuals-with-asthma-copd

https://www.healio.com/news/pulmonology/20210316/study-supports-early-discharge-ambulatory-rivaroxaban-in-lowrisk-pulmonary-embolism

https://www.healio.com/news/pulmonology/20210318/lowrisk-status-achieved-or-maintained-in-minority-of-patients-on-pah-combination-therapy